Key Laboratory of Radiological Protection and Nuclear Emergency, China CDC, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention, Beijing 100088 China
彭玄, 拓飞. 人体甲状腺中131I的测量方法进展[J]. 中国辐射卫生, 2020, 29(3): 313-317.
PENG Xuan, TUO Fei. Progress in measurement of 131I in human thyroid. , 2020, 29(3): 313-317.
[1] 郑红宾. 131I治疗甲状腺疾病的辐射防护问题[J]. 临床和实验医学杂志,2007,6(9):139 [2] Yordanova A, Eppard E, Kürpig S, et al. Theranostics in nuclear medicine practice[J]. Onco Targets Ther, 2017, 10: 4821-4828 [3] Mihailovic J. Current concepts of 131I therapy in oncology: Indications, methods and follow up[J]. Arch Oncol, 2006, 14: 45-51 [4] Alkhorayef M, Sulieman A, Mohamed-Ahmed M, et al. Staff and ambient radiation dose resulting from therapeutic nuclear medicine procedures[J]. Appl Radiat Isot, 2018, 141: 270-274 [5] 刘明, 耿建华, 梁颖. 核医学治疗分化型甲状腺癌场所空气中131I浓度的研究进展[J]. 中国辐射卫生,2019,28(6):734-736 [6] Azizi M, Mowlavi A. Comparison of the light charged particles on scatter radiation dose in thyroid hadron therapy[J]. J Biomed Phys Eng, 2014, 4(3): 75-82 [7] 中华医学会核医学分会. 2018年全国核医学现状普查结果简报[J]. 中华核医学与分子影像杂志,2018,38(12):813-814 [8] 彭建亮. 131I放射性药物生产工作人员剂量估算与评价[J]. 中国辐射卫生,2019,28(6):662-664 [9] International Atomic Energy Agency. IAEA Safety Standards Series no. RSG-1.2. Assessment of occupational exposure due to intakes of radionuclides[R]. Vienna: IAEA, 1999. [10] 中华人民共和国国家卫生和计划生育委员会. GBZ 129—2016职业性内照射个人监测规范[S]. 北京: 中国标准出版社, 2016. [11] 王红波, 张庆召, 张震, 等. 核医学科工作人员职业性内照射研究进展[J]. 中国辐射卫生,2016,25(2):251-254 [12] 郑传城, 华威, 王旭, 等. 放射性核素体内污染的两种检测方法比较[J]. 中国辐射卫生,2009,18(1):26-27 [13] 王红波. 核医学科工作人员职业性内照射研究[D]. 北京: 中国疾病预防控制中心, 2017. [14] Tokonami S, Hosoda M, Akiba S, et al. Thyroid doses for evacuees from the Fukushima nuclear accident[J]. Sci Rep, 2012, 2: 507 [15] Krajewska G, Pachocki KA. Assessment of exposure of workers to ionizing radiation from radioiodine and technetium in nuclear medicine departmental facilities[J]. Med Pr, 2013, 64(5): 625-630 [16] Dantas BM, Lima FF, Dantas AL, et al. Determination of uncertainties associated to the in vivo measurement of iodine-131 in the thyroid[J]. Appl Radiat Isot, 2016, 113: 1-4 [17] 马加一, 史晓东. 体外直接检测法评估南京市3家医院核医学工作人员的内照射个人剂量水平[J]. 环境与职业医学,2019,36(6):549-553 [18] Hosoda M, Iwaoka K, Tokonami S, et al. Comparative study of performance using five different Gamma-ray spectrometers for thyroid monitoring under nuclear emergency situations[J]. Health Phys, 2019, 116(1): 81-87 [19] Kurihara O, Nakagawa T, Takada C, et al. Internal doses of three persons staying 110 KM south of the fukushima daiichi nuclear power station during the arrival of radioactive plumes based on direct measurements[J]. Radiat Prot Dosimetry, 2016, 170(1/2/3/4): 420-424 [20] Uchiyama K, Miyashita M, Tanishima Y, et al. Use of iodine-131 to tellurium-132 ratios for assessing the relationships between human inhaled radioactivity and environmental monitoring after the accident in fukushima[J]. Int J Environ Res Public Health, 2018, 15(3): E483 [21] Matsuda N, Kumagai A, Ohtsuru A, et al. Assessment of internal exposure doses in Fukushima by a whole body counter within one month after the nuclear power plant accident[J]. Radiat Res, 2013, 179(6): 663-668 [22] Brudecki K, Kowalska A, Zagrodzki P, et al. Measurement of 131I activity in thyroid of nuclear medical staff and internal dose assessment in a Polish nuclear medical hospital[J]. Radiat Environ Biophys, 2017, 56(1): 19-26 [23] Lucena EA, Rebelo AM, Araújo F, et al. Evaluation of internal exposure of nuclear medicine staff through in vivo and in vitro bioassay techniques[J]. Radiat Prot Dosimetry, 2007, 127(1/2/3/4): 465-468 [24] Kamada N, Saito O, Endo S, et al. Radiation doses among residents living 37 km northwest of the Fukushima Dai-ichi Nuclear Power Plant[J]. J Environ Radioact, 2012, 110: 84-89 [25] International Commission on Radiological Protection. ICRP Publication 78. Individual monitoring for internal exposure of workers (preface and glossary missing)[R]. Oxford: Pergamon Press, 1997. [26] International Commission on Radiological Protection. ICRP Publication 71. Age-dependent doses to members of the public from intake of radionuclides: Part 4[R]. Oxford: Pergamon Press, 1995. [27] International Commission on Radiological Protection. ICRP Publication 56. Age-dependent doses to members of the public from intake of radionuclides: Part 1[R]. Oxford: Pergamon Press, 1990. [28] Brudecki K, Szczodry A, Mróz T, et al. Measurement of 131I activity in air indoor Polish nuclear medical hospital as a tool for an internal dose assessment[J]. Radiat Environ Biophys, 2018, 57(1): 77-82 [29] Hoi TX, Phuong HT, van Hung N. Estimating the internal dose for 131I production workers from air sampling method[J]. Radiat Prot Dosimetry, 2017, 175(1): 58-64 [30] Ohba T, Hasegawa A, Suzuki G. Estimated thyroid inhalation doses based on body surface contamination levels of evacuees after the fukushima daiichi nuclear power plant accident[J]. Health Phys, 2019, 117(1): 1-12 [31] Bitar A, Maghrabi M, Doubal AW. Assessment of intake and internal dose from iodine-131 for exposed workers handling radiopharmaceutical products[J]. Appl Radiat Isot, 2013, 82: 370-375 [32] Kim ST, Yoo JR, Park JM. An investigation into internal exposure management needs for nuclear medicine practitioners and temporary visitors through I-131 internal dose assessment: Focusing on large hospitals in South Korea[J]. PLoS One, 2018, 13(12): e0209244 [33] Yajima K, Eunjoo K, Tani K, et al. A reliable and robust method for monitoring large populations to assess thyroid internal exposure in a nuclear accident: A proposal based on experiences from Fukushima[J]. BIO Web Conferences, 2019, 14: 03010